Peptide Cancer Vaccines
2 articles in this topic.
Peptide Cancer Vaccines
WT1 Peptide Vaccine for Leukemia
WT1 is the top-ranked cancer antigen for immunotherapy. Galinpepimut-S, a WT1 peptide vaccine, is in phase 3 trials for AML. Here's where the evidence stands.
13 min read|Mar 26, 2026
Peptide Cancer Vaccines
gp100 Peptide Vaccine for Melanoma: Trial History
The gp100 peptide vaccine for melanoma: clinical trial results from IL-2 combinations to the ipilimumab trial and what it taught cancer immunotherapy.
13 min read|Mar 22, 2026